Lunit Inc. (KOSDAQ: 328130)

South Korea flag South Korea · Delayed Price · Currency is KRW
43,100
+2,700 (6.68%)
Nov 14, 2024, 9:00 AM KST
-54.25%
Market Cap 1.77T
Revenue (ttm) 26.03B
Net Income (ttm) -22.06B
Shares Out 28.94M
EPS (ttm) -1,952.88
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 988,396
Open 41,200
Previous Close 40,400
Day's Range 40,750 - 43,750
52-Week Range 31,000 - 100,500
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Nov 13, 2024

About Lunit

Lunit Inc. develops and provides AI based software solutions for cancer screening/diagnosis and treatment. It offers AI solution for chest X-ray and mammography, as well as AI-powered biomarker for immune phenotyping and PD-L1 quantification for immunotherapy. The company was incorporated in 2013 and is based in Seoul, South Korea. [Read more]

Industry Prepackaged Software
Founded 2013
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 328130
Full Company Profile

Financial Performance

In 2023, Lunit's revenue was 25.08 billion, an increase of 80.88% compared to the previous year's 13.87 billion. Losses were -36.80 billion, -5.93% less than in 2022.

Financial Statements

News

There is no news available yet.